News from leap therapeutics, inc. A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.

Latest

Feb 22, 2021, 07:00 ET Leap Therapeutics to Present at Upcoming Virtual Investor Conferences

Leap Therapeutics, Inc. (Nasdaq:LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today announced that...

Jan 06, 2021, 07:00 ET Leap Therapeutics to Present at H.C. Wainwright BioConnect 2021 Conference

Leap Therapeutics, Inc. (Nasdaq:LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today announced that...

Jan 04, 2021, 07:00 ET Leap Therapeutics to Present at 39th Annual J.P. Morgan Healthcare Conference

Leap Therapeutics, Inc. (Nasdaq:LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today announced that...

Dec 22, 2020, 10:17 ET Leap Therapeutics Announces Publication of DKN-01 Mechanism of Action Data in Molecular Cancer Research

Leap Therapeutics, Inc. (Nasdaq:LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today announced the...

Nov 23, 2020, 07:00 ET Leap Therapeutics to Participate at Piper Sandler 32nd Annual Virtual Healthcare Conference

Leap Therapeutics, Inc. (Nasdaq:LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today announced that...

Nov 12, 2020, 07:00 ET Leap Therapeutics Reports Third Quarter 2020 Financial Results

Leap Therapeutics, Inc. (Nasdaq:LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today reported...

Nov 10, 2020, 07:00 ET Leap Therapeutics to Present at Stifel 2020 Healthcare Conference

Leap Therapeutics, Inc. (Nasdaq:LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today announced that...

Nov 09, 2020, 09:30 ET Leap Therapeutics Presents DKN-01 Monotherapy Data at AACR Virtual Special Endometrial Cancer Conference

Leap Therapeutics, Inc. (Nasdaq:LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today announced the...

Nov 09, 2020, 08:00 ET Leap Therapeutics Presents Updated Data for DKN-01 in Esophagogastric Cancer Patients at SITC 2020 35th Annual Meeting

Leap Therapeutics, Inc. (Nasdaq: LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today announced the...

Oct 15, 2020, 07:00 ET Leap Therapeutics to Present Esophagogastric Cancer Data at SITC 2020 Annual Meeting

Leap Therapeutics, Inc. (Nasdaq:LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today announced the...

Sep 24, 2020, 07:00 ET Leap Therapeutics Announces FDA Fast Track Designation Granted to DKN-01 for the Treatment of Gastric and Gastroesophageal Junction Cancer

Leap Therapeutics, Inc. (Nasdaq:LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today announced that...

Sep 21, 2020, 07:00 ET Leap Therapeutics and BeiGene Announce First Patient Dosed in Study of DKN-01 in Combination with Tislelizumab for the Treatment of Metastatic Gastric or Gastroesophageal Junction Cancer

Leap Therapeutics, Inc. (Nasdaq:LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, and BeiGene, Ltd.,...

Sep 09, 2020, 07:00 ET Leap Therapeutics to Present at H.C. Wainwright 22nd Annual Global Investment Conference

Leap Therapeutics, Inc. (Nasdaq:LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today announced that...

Aug 24, 2020, 07:00 ET Leap Therapeutics Expands Leadership Team with Addition of Two Industry Veterans

Leap Therapeutics, Inc. (Nasdaq: LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today announced the...

Aug 13, 2020, 07:00 ET Leap Therapeutics Reports Second Quarter 2020 Financial Results

Leap Therapeutics, Inc. (Nasdaq:LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today reported...

Jun 25, 2020, 16:05 ET Leap Therapeutics Announces Full Exercise of Underwriters' Option to Purchase Additional Shares

Leap Therapeutics, Inc. (NASDAQ: LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today announced the...

Jun 22, 2020, 16:05 ET Leap Therapeutics Announces Closing of Public Offering of Common Stock and Pre-Funded Warrants

Leap Therapeutics, Inc. (NASDAQ:LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today announced the...

Jun 18, 2020, 09:00 ET Leap Therapeutics Announces Pricing of $45 Million of Common Stock and Pre-Funded Warrants

Leap Therapeutics, Inc. (NASDAQ:LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today announced the...

Jun 17, 2020, 16:01 ET Leap Therapeutics Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants

Leap Therapeutics, Inc. (NASDAQ:LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today announced that...

Jun 11, 2020, 16:06 ET Leap Therapeutics Announces Oprhan Drug Designation of DKN-01 for the Treatment of Gastric and Gastroesophageal Junction Cancer

Leap Therapeutics, Inc. (Nasdaq:LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today announced that...

Jun 11, 2020, 16:05 ET Leap Therapeutics Announces Changes to Virtual Format and Time for 2020 Annual Meeting of Stockholders

Leap Therapeutics, Inc. (Nasdaq: LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today announced...

May 14, 2020, 07:00 ET Leap Therapeutics Reports First Quarter 2020 Financial Results

Leap Therapeutics, Inc. (Nasdaq: LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today reported...

Apr 23, 2020, 07:00 ET Leap Therapeutics to Present Updated Data for DKN-01 Monotherapy and Paclitaxel Combination In Gynecologic Cancers

Leap Therapeutics, Inc. (Nasdaq: LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today announced...

Mar 18, 2020, 07:00 ET Leap Therapeutics Announces Executive Leadership Changes

Leap Therapeutics, Inc. (Nasdaq: LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today announced...

Mar 16, 2020, 07:00 ET Leap Therapeutics Reports Fourth Quarter and Full Year 2019 Financial Results

Leap Therapeutics, Inc. (Nasdaq: LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today reported...